NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
Follow-Up Questions
NLS Pharmaceutics AG のCEOは誰ですか？
Mr. Alexander Zwyer は NLS Pharmaceutics AG の Chief Executive Officer で、2015 から在籍しています。
